thisdrug what a medicine's name tells you

WHO naming stem · suffix · 32 listed names

-dotin

synthetic derivatives of dolastatin series

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -dotin as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -dotin. So the letters dotin sit at the end of the name (…dotin).

All 32 names WHO lists under -dotin

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. anvatabart opadotin
  2. aprutumab ixadotin
  3. azintuxizumab vedotin
  4. belantamab mafodotin
  5. brentuximab vedotin
  6. cemadotin
  7. cofetuzumab pelidotin
  8. denintuzumab mafodotin
  9. depatuxizumab mafodotin
  10. enapotamab vedotin
  11. enfortumab vedotin
  12. glembatumumab vedotin
  13. iladatuzumab vedotin
  14. indusatumab vedotin
  15. ladiratuzumab vedotin
  16. lifastuzumab vedotin
  17. lonigutamab ugodotin
  18. losatuxizumab vedotin
  19. pinatuzumab vedotin
  20. polatuzumab vedotin
  21. samrotamab vedotin
  22. sirtratumab vedotin
  23. soblidotin
  24. sofituzumab vedotin
  25. tasidotin
  26. telisotuzumab vedotin
  27. tisotumab vedotin
  28. trastuzumab botidotin
  29. upinetatug rilsodotin
  30. vandortuzumab vedotin
  31. vorsetuzumab mafodotin
  32. zanidatamab zovodotin

Decode another name

Decoded

cemadotin

Listed INNCarries the WHO stem -dotin

  • -dotinend of the nameWHO lists it hereWHO definition: synthetic derivatives of dolastatin series

“cemadotin” is an INN that WHO lists under -dotin in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -dotin (Part II B) and the 32 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.